MedPath

Orilissa

These highlights do not include all the information needed to use ORILISSA safely and effectively. See full prescribing information for ORILISSA. ORILISSA (elagolix) tablets, for oral use Initial U.S. Approval: 2018

Approved
Approval ID

a86757b3-09c5-fd3b-1223-244e94f50a66

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 5, 2023

Manufacturers
FDA

AbbVie Inc.

DUNS: 078458370

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Elagolix

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0074-0038
Application NumberNDA210450
Product Classification
M
Marketing Category
C73594
G
Generic Name
Elagolix
Product Specifications
Route of AdministrationORAL
Effective DateJune 8, 2023
FDA Product Classification

INGREDIENTS (11)

ELAGOLIX SODIUMActive
Quantity: 150 mg in 1 1
Code: 5948VUI423
Classification: ACTIM
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
SODIUM CARBONATE MONOHYDRATEInactive
Code: 2A1Q1Q3557
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
CARMINIC ACIDInactive
Code: CID8Z8N95N
Classification: IACT

Elagolix

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0074-0039
Application NumberNDA210450
Product Classification
M
Marketing Category
C73594
G
Generic Name
Elagolix
Product Specifications
Route of AdministrationORAL
Effective DateJune 8, 2023
FDA Product Classification

INGREDIENTS (11)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
SODIUM CARBONATE MONOHYDRATEInactive
Code: 2A1Q1Q3557
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
ELAGOLIX SODIUMActive
Quantity: 200 mg in 1 1
Code: 5948VUI423
Classification: ACTIM
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Orilissa - FDA Drug Approval Details